HomeCompareGVP vs MRK

GVP vs MRK: Dividend Comparison 2026

GVP yields 43.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GVP wins by $224.4K in total portfolio value
10 years
GVP
GVP
● Live price
43.57%
Share price
$4.59
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$281.2K
Annual income
$50,984.43
Full GVP calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GVP vs MRK

📍 GVP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGVPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GVP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GVP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GVP
Annual income on $10K today (after 15% tax)
$3,703.70/yr
After 10yr DRIP, annual income (after tax)
$43,336.77/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GVP beats the other by $35,008.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GVP + MRK for your $10,000?

GVP: 50%MRK: 50%
100% MRK50/50100% GVP
Portfolio after 10yr
$169.0K
Annual income
$30,391.28/yr
Blended yield
17.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GVP
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-4.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GVP buys
0
MRK buys
0
No recent congressional trades found for GVP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGVPMRK
Forward yield43.57%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$281.2K$56.8K
Annual income after 10y$50,984.43$9,798.13
Total dividends collected$216.7K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: GVP vs MRK ($10,000, DRIP)

YearGVP PortfolioGVP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,057$4,357.30$11,206$366.19+$3.9KGVP
2$22,243$6,131.70$12,650$502.35+$9.6KGVP
3$32,265$8,465.32$14,407$694.19+$17.9KGVP
4$46,000$11,476.31$16,585$967.82+$29.4KGVP
5$64,511$15,291.22$19,342$1,363.89+$45.2KGVP
6$89,069$20,041.73$22,913$1,947.19+$66.2KGVP
7$121,165$25,860.75$27,662$2,823.89+$93.5KGVP
8$162,524$32,878.08$34,159$4,173.35+$128.4KGVP
9$215,117$41,215.92$43,337$6,308.80+$171.8KGVP
10$281,159$50,984.43$56,776$9,798.13+$224.4KGVP

GVP vs MRK: Complete Analysis 2026

GVPStock

GSE Systems, Inc. provides professional and technical engineering, staffing services, and simulation software to the power and process industries in the United States, Asia, Europe, and internationally. It operates in two segments, Performance Improvement Solutions and Workforce Solutions. The Performance Improvement Solutions segment provides various simulation products, engineering services, and operation training systems for the nuclear, fossil fuel power generation, and process industries. The Workforce Solutions segment supports project lifecycles and provides specialized and skilled talent for energy and engineering industries, which include reactor operations instructors, procedure writers, project managers, engineers, work management specialists, planners, and training material developers. It markets its products and services through a network of direct sales staff, agents and representatives, and strategic alliance partners. The company was founded in 1971 and is headquartered in Columbia, Maryland.

Full GVP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GVP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GVP vs SCHDGVP vs JEPIGVP vs OGVP vs KOGVP vs MAINGVP vs JNJGVP vs ABBVGVP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.